Filtros de búsqueda

Lista de obras de Julie Martin

A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial

artículo científico publicado en 2008

A West Nile Virus DNA Vaccine Induces Neutralizing Antibody in Healthy Adults during a Phase 1 Clinical Trial

artículo científico publicado en 2007

A phase I trial of PX-12, a small-molecule inhibitor of thioredoxin-1, administered as a 72-hour infusion every 21 days in patients with advanced cancers refractory to standard therapy.

artículo científico publicado en 2011

An open-label clinical trial evaluating safety and pharmacokinetics of two dosing schedules of panitumumab in patients with solid tumors

artículo científico publicado en 2009

Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients

artículo científico

Comprehensive Characterization of Cancer Driver Genes and Mutations

article

Effects of ketoconazole and esomeprazole on the pharmacokinetics of pazopanib in patients with solid tumors ⬇️

artículo científico publicado el 1 de mayo de 2013

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine

artículo científico publicado en 2006

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector

artículo científico publicado en 2006

Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine

scientific article published on 07 March 2007

Randomized phase 2 study of the cyclin-dependent kinase inhibitor dinaciclib (MK-7965) versus erlotinib in patients with non-small cell lung cancer

artículo científico publicado en 2013

Relative dominance of epitope-specific CD8+ T cell responses in an F1 hybrid mouse model of respiratory syncytial virus infection

artículo científico publicado en 2007

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

article

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda